NCT06158152View on ClinicalTrials.gov

A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

March 1, 2026

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

AM3 + Probiotic

Two capsules daily in the morning during 12 weeks. The capsule contains the mixture of AM3 Technology and probiotic SynBalance Metsyn.

DIETARY_SUPPLEMENT

Placebo

Two capsules daily in the morning during 12 weeks. The capsule contains starch.

DIETARY_SUPPLEMENT

AM3

Two capsules daily in the morning during 12 weeks. The capsule contains AM3 Technology.

Trial Locations (2)

Unknown

RECRUITING

Hospital Universitario Infanta Leonor, Madrid

RECRUITING

Hospital Universitario Príncipe de Asturias, Madrid

All Listed Sponsors
lead

Industrial Farmacéutica Cantabria, S.A.

INDUSTRY